Central Serotonergic Activity is Related to the Aggressive Behaviors of Alzheimer's Disease

Author： Lanctot K.L.   Herrmann N.   Eryavec G.   van Reekum R.   Reed K.   Naranjo C.A.  

Publisher： Elsevier

ISSN： 0893-133X

Source： Neuropsychopharmacology, Vol.27, Iss.4, 2002-10, pp. : 646-654

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis and cholinesterase activity of phenylcarbamates related to Rivastigmine, a therapeutic agent for Alzheimer's disease

By Mustazza C.   Borioni A.   Giudice M.R.D.   Gatta F.   Ferretti R.   Meneguz A.   Volpe M.T.   Lorenzini P.  

European Journal of Medicinal Chemistry, Vol. 37, Iss. 2, 2002-02 ,pp. : 91-109

Elsevier

Access to resources Recommend Favorite

Alzheimer's Disease Related

By  

Current Bioactive Compounds, Vol. 2, Iss. 4, 2006-12 ,pp. : 503-503

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer’s Disease

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2064-2071

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonergic modulation of central respiratory activity in the neonatal mouse: an in vitro study

By Hilaire G.   Bou C.   Monteau R.  

European Journal of Pharmacology, Vol. 329, Iss. 2, 1997-06 ,pp. : 115-120

Elsevier

Access to resources Recommend Favorite

Alzheimer’s disease and related dementias:

By Williams M.   Davis R.E.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 6, 1997-06 ,pp. : 735-759

Informa Healthcare

Access to resources Recommend Favorite